Last reviewed · How we verify

NCT04855474

Protein Requirements in Male and Female Endurance Athletes

Completed NA Last updated 13 July 2023
What this trial tests

NA trial testing Amino Acid Intake in Increased Metabolic Requirement in 16 participants. Completed in 30 December 2022.

Timeline
8 March 2021
Primary endpoint
31 October 2021
30 December 2022

Quick facts

Lead sponsorUniversity of Toronto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment16
Start date8 March 2021
Primary completion31 October 2021
Estimated completion30 December 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Toronto

Who can join

Adults 18 to 35, any sex, with Increased Metabolic Requirement or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Protein is an essential macronutrient for post-exercise recovery through its ability to provide the amino acid building blocks that support increased rates of muscle and whole body protein synthesis. Despite the growing understanding of the importance of post-exercise protein in endurance athlete populations, the impact of sex and female menstrual cycle phase on protein metabolism is not fully understood. To date, no studies have examined protein requirements in female endurance trained athletes. The aim of the proposed study is to utilize the well-established IAAO method to determine protein requirements in endurance trained female and male athletes in a "real-world" and at-home setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Amino Acid Intake

Trials testing the same drug.

Other University of Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04855474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing